Helius Medical Technologies to Showcase Innovations at Key Conference
Introduction to Helius Medical Technologies
Helius Medical Technologies, Inc. is a pioneering neurotechnology company focused on developing innovative therapeutic solutions aimed at addressing neurogenic balance and gait disorders. Known for its commitment to enhancing patient outcomes, Helius has made significant strides in the medical device sector by offering cutting-edge neuromodulation technologies.
Participation in The ThinkEquity Conference
On October 30, 2024, Helius Medical Technologies will participate in The ThinkEquity Conference, held at the prestigious Mandarin Oriental Hotel in New York. This prominent event serves as a convergence point for institutional investors, corporate leaders, and industry experts to discuss and explore financial strategies and groundbreaking innovations.
Presentation Schedule
The management team will present at 4:30 PM ET, showcasing the company's advancements and future goals. Moreover, they will engage in one-on-one meetings with potential investors throughout the day, providing a unique opportunity for personalized discussions and insights into the company's operations.
About The ThinkEquity Conference
The ThinkEquity Conference is a well-regarded investment banking event organized by seasoned professionals with extensive experience in capital financing. The event boasts a rich history of over 70 company presentations, attracting more than 700 attendees and facilitating over 500 one-on-one meetings. This creates a dynamic platform for networking and collaboration, essential for the growth of businesses and investors alike.
Connecting with Investors
For investors interested in attending or scheduling one-on-one meetings with Helius Medical Technologies, registration is straightforward. The event presents a valuable opportunity for investors to connect intimately with the company’s leaders and gain deeper insights into their innovative approaches.
Helius Medical’s Innovative Solutions
Helius Medical Technologies stands at the forefront of neurotechnology, focusing on addressing neurologic deficits through an innovative oral technology platform. This platform empowers the brain, enabling it to engage physiological compensatory mechanisms and promote neuroplasticity. These advancements are designed to significantly improve the quality of life for individuals coping with various neurologic conditions.
Flagship Product: Portable Neuromodulation Stimulator
The company's flagship product, the Portable Neuromodulation Stimulator, is a testament to Helius's commitment to delivering effective neurological therapies. This device has shown promising results in clinical settings, providing users with an accessible means of managing their symptoms and enhancing their overall well-being.
Looking Ahead
As Helius Medical Technologies endeavors to expand its reach and impact in the neurotech landscape, the upcoming ThinkEquity Conference serves as a vital platform for establishing meaningful connections and showcasing their pioneering solutions. Investors can anticipate insightful discussions and a comprehensive overview of the company’s current trajectory and future aspirations.
Contact Information for Investors
Helius Medical Technologies values transparency and communication with its stakeholders. For any inquiries regarding the company or its innovative technologies, interested parties can reach out through their investor relations contact: Philip Trip Taylor at Gilmartin Group. The company encourages investors to get in touch to explore collaborative opportunities.
Frequently Asked Questions
What is the main focus of Helius Medical Technologies?
Helius Medical Technologies concentrates on developing therapeutic technologies for balance and gait disorders resulting from neurological conditions.
When and where will the ThinkEquity Conference take place?
The ThinkEquity Conference is scheduled for October 30, 2024, at the Mandarin Oriental Hotel in New York.
How can investors participate in the conference?
Investors can register to attend the conference and schedule one-on-one meetings with Helius’s management teams for personalized discussions.
What is Helius Medical's flagship product?
The flagship product is the Portable Neuromodulation Stimulator, designed to help manage symptoms associated with neurological diseases.
How can investors get in touch with Helius Medical Technologies?
Investors can contact Philip Trip Taylor at Gilmartin Group for inquiries related to investment opportunities and company insights.
About Investors Hangout
Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/
Disclaimer: The content of this article is solely for general informational purposes only; it does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice; the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. The author's interpretation of publicly available data shapes the opinions presented here; as a result, they should not be taken as advice to purchase, sell, or hold any securities mentioned or any other investments. The author does not guarantee the accuracy, completeness, or timeliness of any material, providing it "as is." Information and market conditions may change; past performance is not indicative of future outcomes. If any of the material offered here is inaccurate, please contact us for corrections.
Related Articles
- Exciting Launch of Hot Wheels Monster Trucks on All Platforms
- Biological Lattice Industries Lands Major Funding for Innovation
- Innovative Student Projects Shine at 2024 Collegiate Inventors Gala
- ADTRAN Holdings Set to Announce 2024 Q3 Earnings Soon
- Exciting Growth Ahead for REI Co-op with New Store Openings
- Genians Expands Operations with New Office in Dubai to Boost MEA Cybersecurity
- Ryan Murphy Celebrates Grand Opening of Swim School in Florida
- Hepsiburada Enters Agreement to Sell Class A and B Shares
- Transforming a Classic: The WhippleD Chevelle's Debut at SEMA
- Clockwork Sets Stage for Innovation at Major Industry Events
Recent Articles
- Exciting New Home Community Launched by KB Home in Florida
- Alignment Healthcare Sets Stage for Q3 2024 Financial Call
- Vertex Pharmaceuticals Showcases Pivotal Phase 3 Data for Suzetrigine
- SpaceX and NASA Partner for Upcoming ISS Missions in 2025
- Madrigal Pharmaceuticals Plans Exciting Q3 Financial Results Event
- Ferring Pharmaceuticals Showcases Innovations in Fertility Care
- FOREWARN Partners with REALTORS® for Enhanced Safety Tools
- Bitcoin's Surge: Impact on Altcoins and Future Strategies
- Key Updates on Tryg Share Trading Activity Among Executives
- Cyber A.I. Group Partners to Drive Strategic Growth Initiatives
- Heliogen Welcomes Apurba Das as the New CTO to Drive Innovation
- Octopus Future Generations VCT Enhances Offering Strategy
- Helius Medical Technologies Highlights Innovations at Conference
- Valour's Strategic Shift to Spotlight to Boost ETP Market Presence
- Butterfly Network to Reveal Q3 2024 Results in Upcoming Call
- Alignment Healthcare Set to Reveal Q3 2024 Financials Soon
- Madrigal Pharmaceuticals' Upcoming Third-Quarter Results Webcast
- Pending Home Sales Surge Indicates a Shifting Market Trend
- Class Action Alert: Paragon 28 Faces Legal Challenges Ahead
- Republic Bancorp's Q3 2024 Performance: A Bright Future Ahead
- RXR and Hudson Bay Capital Join Forces for Prestigious Upgrade
- Exploring Undervalued Energy Stocks Poised for Growth
- Celebrating Indigenous Economic Excellence: The 2024 Winners
- LOST MARY Establishes Expert Advisory Board to Enhance Strategy
- Sierra Bancorp Unveils New Buyback Plan and Cash Dividend
- Pan Global Secures $7 Million Financing Amid High Demand
- Empowering Inclusive Futures: Nora Project's Training Initiative
- AffableBPM Joins Creative Destruction Lab to Transform Healthcare
- Laramide Enhances Financial Flexibility with New Lending Agreement
- cTRL Therapeutics to Showcase Innovative Cancer Treatment Data
- Ally Financial Shares Strong Third Quarter Results Announcement
- Centro Expands Its Platform to Redefine Broker-Carrier Dynamics
- MicroSalt Experiences Notable Share Price Increase Amid Updates
- Valvoline Inc. CFO Mary Meixelsperger to Retire Soon
- Piper Sandler Adjusts Microsoft Outlook Amidst Earnings Concerns
- OURHOME to Showcase Innovative K-Food at Major Event
- Gore Street Energy Storage Fund Secures Major $14M Contract
- TSC Alliance Celebrates 50 Years of Progress in TSC Support
- Future plc Faces Leadership Change as Jon Steinberg Resigns
- Tech Giants Show Gains; Financial Sector Faces Challenges
- Unexpected Trends in Holiday Travel This Season
- Nixxy's Strategic Spin-Off Sparks AI Innovations and Growth
- Transforming 620 Avenue of the Americas: A New Beginning
- Citi Cuts Liberty Oilfield Services to Neutral, Price Target Adjusted
- Highlighting Growth: Join New England's Fastest Companies
- Mizuho Boosts DraftKings Stock Target on Earnings Outlook
- Kahoot! Achieves Gold Certification in Educational Equity
- Optimistic Outlook for Aura Biosciences Following Positive Data
- Cytokinetics Maintains Strong Outlook Amid Positive Analyst Ratings
- Tenaya Therapeutics Makes Strides in MYBPC3-HCM Trials